Hims & Hers Health (HIMS) shares were down 1.6% in recent Friday trading after Citigroup downgraded the company's stock to sell from neutral.
Citigroup adjusted its price target for Hims & Hers shares to $25 From $24.
Trading volume stood at over 7.1 million shares against a daily average of about 16.2 million.
Price: 25.33, Change: -0.40, Percent Change: -1.55